News

Not Ozempic, in India THIS weigh-loss and diabetes drug from Eli Lilly sees sales jump 60% — what is it?
Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The ...
CNBCTV183h
Lilly’s obesity drug sales rise 60% in India amid rising demand
Eli Lilly & Co. increased sales of the weight-loss and diabetes drug Mounjaro 60% in India in May from April in its second ...
ScandAsia8h
Novo Nordisk and HSRI partner to raise Thailand’s clinical research standards
Novo Nordisk Thailand has signed an MoU with HSRI – and the Health Systems Research Institute  – to strengthen Thailand’s clinical research infrastructure and foster healthcare innovation. The ...
MarketBeat on MSN23h
With Novo Nordisk's CEO Out, Wall Street Wants an American Leader
CompanyOverview|NYSE:NVO] Despite a massively successful run as Chief Executive Officer (CEO) of pharma giant Novo Nordisk ...